Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study

Area of Science:

• Medicine
• Pulmonology
• Critical Care

Background:

• Severe acute respiratory failure (ARF) presents a significant therapeutic challenge.
• Conventional mechanical ventilation has limitations in supporting critically ill patients.
• Extracorporeal membrane oxygenation (ECMO) offers an alternative for respiratory support.

Purpose of the Study:

• To evaluate the efficacy of prolonged extracorporeal membrane oxygenation (ECMO) in treating severe acute respiratory failure (ARF).
• To compare survival rates between conventional mechanical ventilation and ECMO-assisted mechanical ventilation.

Main Methods:

• Prospective randomized study involving nine medical centers.
• Ninety adult patients with severe ARF and arterial hypoxemia were enrolled.
• Patients were randomized to conventional mechanical ventilation (n=48) or ECMO-supplemented partial venoarterial bypass (n=42).

Main Results:

• Survival rates were low in both groups, with four survivors in each arm.
• The majority of patients (57%) had acute bacterial or viral pneumonia.
• Patients with pulmonary embolism and posttraumatic ARF had 100% and high mortality, respectively.
• Common causes of death included progressive gas exchange reduction and decreased lung compliance due to inflammation, necrosis, and fibrosis.

Conclusions:

• ECMO effectively supports respiratory gas exchange in severe ARF.
• Prolonged ECMO therapy did not significantly increase long-term survival probability for patients with severe ARF.
• The underlying cause of ARF and diffuse pulmonary pathology significantly impact patient outcomes.